Appendix. Supplementary figures and tables

Similar documents
Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

Staging Sepsis for the Emergency Department: Physician

Supplementary Appendix

Primary fluid bolus therapy for infection-associated

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

Sepsis! Dr Eric Van Den Bergh Consultant in Emergency Medicine 2015

ISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis

Core Measures SEPSIS UPDATES

Initial Resuscitation of Sepsis & Septic Shock

Admissions with severe sepsis in adult, general critical care units in England, Wales and Northern Ireland

Brief summary of the NICE guidelines December 2013

Sepsis: Identification and Management in an Acute Care Setting

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Updates in Sepsis 2017

BREAK 11:10-11:

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

McHenry Western Lake County EMS System CE for Paramedics, EMT-B and PHRN s Sepsis Patients. November/December 2017

Supplementary Appendix

LOKUN! I got stomach ache!

IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING

The changing face of

Inpatient Quality Reporting Program

SUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics

Inflammatory Statements

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

John Park, MD Assistant Professor of Medicine

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Methodological co-investigators

Early lactate clearance rate is an indicator of Outcome in severe sepsis and septic shock

Inpatient Quality Reporting Program

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

Hospital Inpatient Quality Reporting (IQR) Program

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Sepsis Awareness and Education

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Inpatient Quality Reporting (IQR) Program

Sepsis. Reliability- can we achieve Dr Ron Daniels

JAMA. 2016;315(8): doi: /jama

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Printed copies of this document may not be up to date, obtain the most recent version from

Sepsis. National Clinical Guideline Centre. Sepsis: the recognition, diagnosis and management of sepsis. NICE guideline <number> January 2016

Fluid Treatments in Sepsis: Meta-Analyses

Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the

Sepsis. From EMS to ER to ICU. What we need to be doing

National Emergency Laparotomy Audit. Help Box Text

MAKING SENSE OF IT ALL AUGUST 17

Fluids and electrolytes: the basics

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

SUPPLEMENTARY DATA. Supplementary Table S1. Clinical characteristics of the study subjects.*

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Case TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air

Albumina nel paziente critico. Savona 18 aprile 2007

Post-Resuscitation Care. Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena

Supplementary Online Content

3 papers from ED. counting sepsis sepsis 3 wet or dry?

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

ICD-10 Physician Education. Palliative Care SIP

SAH READMISSIONS TO NCCU

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Dextrose 5 normal saline and metronidazole compatible

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

HYPOVOLEMIA AND HEMORRHAGE UPDATE ON VOLUME RESUSCITATION HEMORRHAGE AND HYPOVOLEMIA DISTRIBUTION OF BODY FLUIDS 11/7/2015

The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

Approach to Severe Sepsis. Jan Hau Lee, MBBS, MRCPCH. MCI Children s Intensive Care Unit KK Women s and Children's Hospital, Singapore

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline

Tactical Combat Casualty Care Guideline Change Fluid Resuscitation for Hemorrhagic Shock in TCCC

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

Device Judgement Recommended

Effectively Managing Sepsis Denials

Management of Post Cardiac Arrest Syndrome

Thrombolysis administration

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Troubleshooting Audio

Communicable Diseases EMT REFRESHER NCCP 2018 JTEMPLE

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Jawad Nazir, MD, FACP Medical Director, Infection Prevention and Control Avera Health and Avera McKennan Hospital Clinical Associate Professor of

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

Transfusion Requirements and Management in Trauma RACHEL JACK

SEP-1 CHALLENGING CASES WITH DR. TOWNSEND

Is nosocomial infection the major cause of death in sepsis?

Using the New Hypertension Guidelines

Supplementary Appendix

Evidence- Based Medicine Fluid Therapy

Online Supplementary Appendix

6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,

SURVIVING SEPSIS: Early Management Saves Lives

Diabetes in the Elderly 1, 2, 3

The ABC of CAB- Circulation, Airway, Breathing: PALS/Resuscitation Update

trust clinical guideline

Chapter 5: Sepsis Stephen Lo

Transcription:

This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix. Supplementary figures and tables Figure A1. Flowchart describing patient selection process

Figure A2. Changes in MAP with different fluid bolus volume in the whole cohort. A positive value on the Yaxis indicates a rise in blood pressure 60 Change in MAP after before fluid bolus (mmhg) 40 20 0 20 40 60 80 0 400 800 1200 1600 2000 Bolus amount (mls) r = 0.16; r2 = 0.024; p<0.05

Figure A3. Changes in MAP with different fluid bolus volume in patients that were hypotensive or severly hypotensive on arrvial to the ED. A positive value indicates a rise in blood pressure Change in MAP after before fluid bolus (mmhg) 50 40 30 20 10 0 10 20 y = 6.5 0.0032*x; r = 0.1054; p = 0.2966; r 2 = 0.0111 0 200 400 600 800 1000 Bolus amount (mls)

Figure A4. Changes in mean arterial pressure (MAP) in patients treated with noradrenaline (NA) on arrival to the ED, prior and after the commencement of the NA infusion. The MAP increased after the start of the NA infusion (p>0.01. 120 Mean arterial pressure (mmhg) 100 80 60 40 20 ** Before vs. after NE 0 MAP on arrival Before NA administration After NA administration

Figure A5. Changes in systolic arterial pressure (SAP) in patients who were hypotensive (H) on arrival (SBP < 100 mmhg; H); patients who were severely hypotensive (S) on arrival (SBP < 90 mmhg; S); patients who became hypotensive (NH) and patients who became severely hypotensive (NS) during the first six hours after arrival to the emergency department. Changes are depicted in a box plot. Box: mean ± SE; whisker: mean ± 0.95 confidence interval 140 Systolic arterial pressure (mmhg) 120 100 80 60 40 20 0 0 2 4 6 Time (h) SAP H SAP S SAP NH SAP NS

Figure A6. Scatterplot of the total fluid during the first six hours after arrival to the emergency department and the change in mean arterial pressure during the same period in severely hypotensive patients. A positive value on the Yaxis indicates a rise in blood pressure Change in MAP from arrival to the ED to 6 hours later (mmhg) 50 40 30 20 10 0 10 20 Patients with SBP<90 mmhg on arrvial r=0.52; p<0.05; r 2 =0.27 30 0 1000 2000 3000 4000 5000 6000 7000 Total fluid volume during the first six hours after arrival to the ED (mls)

Table A1. Characteristics of full study cohort and patients receiving fluid bolus therapy All ED patients screened Diagnosis and diagnosis codes Gastroenteritis and colitis of unspecified origin (A09.9) Number of cases scanned Number of patients included 30 3 Perforation of oesophagus (K22.3) 2 0 Urinary tract infection (N39.0) 253 8 Acute abdomen (R10.0) 9 0 Bronchopneumonia, unspecified (J18.0) 12 1 Lobar pneumonia, unspecified (J18.1) 9 1 Acute bronchitis, unspecified (J20.9) 4 0 Acute bronchitis, unspecified (J22) 326 14 Pneumonitis due to food and vomit (J69.0) 148 8 Other specified sepsis (A41.8) 26 10 Sepsis, unspecified (A41.9) 300 54 Bacterial infection, unspecified (A49.9) 8 2 Fluid bolus treated patients Comorbidities No. of observations (in 101 cases) Heart failure 17 Coronary artery disease 17 CODP 15 Diabetes mellitus 12 HIV 0 Hypertension 34 Liver failure 8 History of malignancy 20 Neurological disease 23 History of smoking 35 Sepsis details 50 Urinary sepsis 12 Peritonitis 2 Other intraabdominal processes 15 Abscess in extremities 2 Other causes of sepsis 22 Severe sepsis 75 Septic shock 36 Positive blood culture 18 Antibiotics given within 6 hours from arrival in the emergency department 83

Table A2. Vital signs in different subgroups. Hypotensive patients vs. severely hypotensive patients during the first 6 hours Crystalloids Colloids Packed red cells Fresh frozen plasma Platelets Fraction of inspired O 2 Body temperature ( C) Heart rate (x min1) Systolic blood pressure (mm Hg) Diastolic blood pressure (mm Hg) Mean arterial pressure (mmhg) Hypotensive patients n=25 Severely hypotensive patients On arrival 2 hours 4 hours 6 hours On arrival 2 hours 4 hours 6 hours 0.21(0.21 0.28) 500(05000) 0(00) 580(0 1720) 340(0 750) 500(0 2000) 460(0 700) 785(05000) n=21 480(0 1460) 490(0 1350) 0(0500) 0(0750) 0(0600) 0(00) 00(00) 50(0150) 0(00) 0(00) 0(0150) 0(00) 00(00) 30(0180) 0(00) 0(00) 0(0180) 0(00) 0(0750) 0(0700) 0(00) 0(00) 0(00) 0.21(0.21 0.32) 0.21(0.21 0.32) 0.21(0.21 0.32) 0.21(0.21 0.28) 0.21(0.21 0.28) 0.30(0.21 0.34) 0.28(0.21 0.32) 37.4±1.4 37.0±1.4 36.7±1.2 36.8±1.2* 37.1±1.4 36.5±1.2 36.3±1.2 36.3±1.4 103±25 93±23 90±19 88±21 104±27 97±26 96±21 92±20 106±23*** 105±17 104±15* 103±17 78±11 97±10 95±13 100±21 65±14*** 61±10* 59±12 59±15* 45±8 53±8 53±11 54±12 71±5*** 73±10* 75±16* 76±17 56±8 68±8 66±9 70±14 Respiratory rate (x min 1 ) 18(1623) 18(1622) 18(1622) 18(1622) 18(1620) 19(1822) 18(1620) 18(1820) Arterial SaO 2 98(96 98(97 99(97 98(97 97(9499) 98(97100) 97(9499) 99(97100) 100) 100) 100) 100) Arterial ph 7.37±0.08 7.36±0.08 7.39±0.09 7.40±0.07 7.32±0.09 7.35±0.08 7.41±0.09 7.35±0.06 Arterial PaO 2 (mm Hg) 87±66 151±135 122±76 113±42 32±11 53±35 115±87 112±36 Arterial PaCO 2 (mm 42±11 40±13 37±4 37±6 42±10 39±9 37±2 40±6 Hg) base excess 1.6±4.6 2.6±5.5 1.6±5.4 1.4±3.7 4.3±5.7 3.6±5.4 0.4±6.2 2.5±4.8 (mmol x l 1 ) lactate 2.0(1.2 2.2(1.9 1.8(1.4 2.3(1.5 2.8(2.1 2.0(1.6 (mmol x litre 2.1(1.53.1) 1.8(1.53.0) 2.4) 3.2) 2.3) 3.0) 2.8) 2.8) 1 ) Blood haemoglobin 124±24 122±22 113±22 120±20 115±28 118±22 96±26 123±18 (g x l 1 ) chloride 101±5 102±6 102±7 103±6 100±5 102±4 98±6 104±3 (mmol x l 1 ) 129(71 140(72 123(90 75(5794) 142(85 161(131 20(2020) 90(77

creatinine (µmol x l 1 ) Albumin (g x l 1 ) 149) 160)* 150) 216) 182) 103) 33±6 32±7 31±5 26±11 30±8 28±6 R Range *p<0.05 ***p<0.001

Table A3. Vital signs in different subgroups. Survivors vs. nonsurvivors patients during the first 6 hours On arrival Survivors at 28 days n=75 2 hours 4 hours 6 hours On arrival Nonsurvivors at 28 days n=26 2 hours 4 hours 6 hours Crystalloids 500(0 580(0 500(0 500(0 500(0 400(0 5000) R 1720) R 2000) R 1750) R 1500) R 2500) R Colloids 0(00) R 0(0750) R 0(0700) R 0(0500) R 0(0620) R 0(0500) R Packed red cells 0(00) R 0(00) R 0(0150) R 0(00) R 0(00) R 0(0150) R Fresh frozen plasma 0(00) R 0(00) R 0(0180) R 0(00) R 0(00) R 0(0300) R Platelets 0(00) R 0(00) R 0(0200) R 0(00) R 0(00) R 0(00) R Fraction of inspired O 2 0.21(0.21 0.28) 0.21(0.21 0.32)** 0.21(0.21 0.32)** 0.21(0.21 0.32) 0.28(0.21 0.50) 0.28(0.21 0.44) 0.32(0.21 0.50) 0.32(0.21 0.48) Body temperature ( C) 37.4±1.4 37.0±1.4 36.7±1.2 36.8±1.2** 37.2±1.4 36.4±1.2 36.5±1.1 36.1±0.6 Heart rate (x min1) 103±25* 93±23* 90±19** 88±21*** 118±31 108±28 104±22 102±21 Systolic blood pressure (mm 106±23 105±17 104±15 103±17 99±21 102±25 100±20 99±20 Hg) Diastolic blood pressure (mm 65±14** 61±10 59±12** 59±15 55±16 57±15 53±16 56±13 Hg) Mean arterial pressure (mmhg) 78±16* 76±11 74±11** 74±14 69±17 73±14 68±15 71±11 Respiratory 18(16 18(16 18(16 rate (x min 1 ) 23)** 22)*** 22)** 18(1622) 23(2028) 24(1928) 20(1925) 19(1823) Arterial SaO 2 98(97 98(96 98(97 97(9499) 100)* 100) 100)* 97(9499) 97(9599) 97(9699) 97(9698) Arterial ph 7.37±0.08 7.36±0.08 7.39±0.09 7.40±0.07 7.33±0.13 7.29±0.13 7.30±0.12 7.29±0.17 Arterial PaO 2 (mm Hg) 87±66 151±135 122±76 113±42 73±77 47±15 102±67 107±68 Arterial PaCO 2 (mm Hg) 42±11 40±13* 37±4 37±6* 47±18 53±22 49±13 48±19 base excess (mmol x l 1 ) 1.6±4.6 2.6±5.5 1.6±5.4 1.4±3.7 3.1±6.1 3.4±6.0 3.5±6.0 4.8±6.3 lactate 2.0(1.2 2.1(1.5 2.2(1.9 1.8(1.4 2.0(1.4 3.5(2.3 2.4(1.5 (mmol x litre 1 1.8(1.53.6) ) 2.4) 3.1) 3.2) 2.3) 2.9) 7.0) 4.7) Blood haemoglobin (g x l 1 ) 124±24 122±22 113±22 120±20 119±23 121±24 121±23 114±21 White blood 11.5(7.9 8.5(2.4 20.2(8.6 9.4(6.0 10.6(5.8 12.1(6.6 16.6(16.6 10.6(10.4 cell count (x 10 9 18.5) 16.9) 21.1) 15.6) 15.5) 16.7) 16.6) 10.8) ) sodium (mmol 134±5 135±4 133±5 133±5 135±6 135±6 134±5 135±5 x l 1 ) potassium 4.1±0.7 4.1±0.6* 4.1±0.7 3.8±0.7* 4.4±0.6 4.6±0.7 4.4±0.7 4.5±0.7

(mmol x l 1 ) chloride (mmol x l 1 ) creatinine (µmol x l 1 ) Albumin (g x l 1 ) 101±5 102±6 102±7 103±6 101±5 102±5 103±5 106±6 107(71 149) 129(72 160) 148(90 150) 77(5794) 146(84 197) 150(85 162) 116(38 194) 103(77 274) 33±6 32±7 31±5 26±11 29(2232) 32(2938) 26(2626) 23(1827) R Range *p<0.05 ***p<0.001

Table A4. Mortality in severely hypotensive patients at 6 hours (i.e. the failed early resuscitation group vs. the rest) BP at 6h Alive at 28 days Count Percent Severely hypotensive at 6h Y 12 71 N 5 29 Normotensive at 6h Y 30 68 N 14 32 Hypotensive at 6 h Y 28 80 Missing data Y 5 No difference between mortality ratios. N 7 20

Table A5. Physiological changes over time in the hypotensive on arrival, severely hypotensive on arrival, hypotensive in the ED, severely hypotensive in the ED groups Group based on timing of hypotension Hypotensive on arrival Severely hypotensive on arrival Normotensive on arrival, hypotensive later Normotensive on arrival, severely hypotensive later n 25 21 20 35 Mortality at 30 days (%) 16 38 10 34 0h 6h 0h 6h 0h 6h 0h 6h Crystalloids 1700(22 0 Colloids Packed red cells Fresh frozen plasma Platelets Fraction of inspired O 2 1700(2 00 6000) R 1200(2 90 3630) R 3670) R 0(0 200) R 0(0 1370) R 0(00)R 0(00) R 0(00) R 1350(32 04400) R 0(0 1000) R 0(0 180) R 0(00)R 0(0150) 0(0 150) R 0(00)R 0(0300) 0(00) R 0(00) R 0(00) R 0(0200) 0.21(0.2 10.36) 0.28(0.2 10.32) 0.21(0.2 10.28) 0.28(0. 21 0.32) 36.3±1. 4 0.21(0.21 0.21) 0.21(0. 21 0.32) 36.6±0. 9 0.28(0.21 0.44) 0.25(0.21 0.33) Body 37.0±1. 37.1±1.6 temperature ( C) 2 37.1±1.4 37.6±1.3 37.4±1.3 36.6±0.8 Heart rate (x min 1) 104±29 96±20 104±27 92±20 110±15 92±25 108±32 89±22 Systolic blood pressure (mm Hg) 95±4 104±24 78±11 100±21 124±19 102±10 118±17 102±16 Diastolic blood pressure (mm Hg) 54±8 62±16 45±8 54±12 67±11 59±11 74±14 59±16 Mean arterial pressure (mmhg) 71±5 76±17 56±8 70±14 86±10 73±9 88±14 73±13 Respiratory rate 20(16 20(18 18(16 18(18 19(17 19(17 18(16 (x min 1 21(1828) ) 24) 22) 20) 20) 26) 24) 23) Arterial SaO 2 97(94 98(96 97(94 98(97 97(94 98(97 98(94 97(96 98) 100) 99) 100) 99) 99) 100) 99) Arterial ph 7.40±0.1 7.39±0. 7.32±0.0 7.35±0. 7.36±0.0 7.35±0.1 7.38±0.1 0 14 9 06 8 1 2 Arterial PaO 2 (mm Hg) 104±71 112±36 133±111 93±52 102±29 Arterial PaCO 2 (mm Hg) 41±8 39±11 42±9 40±6 46±17 46±16 41±15 base excess (mmol x l 1.4±4.7 2.9±6.4 4.3±5.7 1 2.5±4.8 ) 0.5±4.8 2.2±5.2 2.0±3.9 lactate (mmol/litre) Blood haemoglobin (g x l 1 ) White blood cell count (x 10 9 ) sodium (mmol x l 1 ) potassium (mmol x l 1 ) 2.1(1.4 2.4) 1.8(1.4 4.7) 2.3(1.5 3.0) 2.0(1.6 2.8) 1.3(1.2 1.9) 2.0(1.3 2.5) 1.7(1.5 2.2) 123±20 110±17 115±28 123±18 129±25 123±22 116±17 10.7(7.1 16.2) 12.4(10. 421.2) 9.6(7.4 17) 10.9(7.0 16.6) 135±5 132±5 132±5 133±3 135±6 135±4 134±5 4.0±0.6 4.0±1.1 4.4±0.8 4.3±0.6 4.0±0.6 4.4±0.7 3.9±0.5

chloride (mmol x l 1 ) creatinine (µmol x l 1 ) Albumin (g x l 1 ) R Range 101±6 101±7 100±5 104±3 100±5 102±5 105±5 107(72 133) 142(85 216) 107±46 138(65 160) 32±6 30±8 32±7 33±6